Menu
GeneBe

rs137853277

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM1BP4_StrongBP6_Very_StrongBS1

The NM_000261.2(MYOC):c.1058C>T(p.Thr353Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000203 in 1,614,024 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★★).

Frequency

Genomes: 𝑓 0.00040 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 1 hom. )

Consequence

MYOC
NM_000261.2 missense

Scores

3
15

Clinical Significance

Likely benign reviewed by expert panel B:3

Conservation

PhyloP100: 1.26
Variant links:
Genes affected
MYOC (HGNC:7610): (myocilin) MYOC encodes the protein myocilin, which is believed to have a role in cytoskeletal function. MYOC is expressed in many occular tissues, including the trabecular meshwork, and was revealed to be the trabecular meshwork glucocorticoid-inducible response protein (TIGR). The trabecular meshwork is a specialized eye tissue essential in regulating intraocular pressure, and mutations in MYOC have been identified as the cause of hereditary juvenile-onset open-angle glaucoma. [provided by RefSeq, Jul 2008]
MYOCOS (HGNC:53429): (myocilin opposite strand)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

PM1
In a disulfide_bond (size 188) in uniprot entity MYOC_HUMAN there are 57 pathogenic changes around while only 11 benign (84%) in NM_000261.2
BP4
Computational evidence support a benign effect (MetaRNN=0.019976467).
BP6
Variant 1-171636382-G-A is Benign according to our data. Variant chr1-171636382-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1013538.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr1-171636382-G-A is described in Lovd as [Likely_pathogenic].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000401 (61/152216) while in subpopulation EAS AF= 0.00927 (48/5176). AF 95% confidence interval is 0.00719. There are 1 homozygotes in gnomad4. There are 35 alleles in male gnomad4 subpopulation. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYOCNM_000261.2 linkuse as main transcriptc.1058C>T p.Thr353Ile missense_variant 3/3 ENST00000037502.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYOCENST00000037502.11 linkuse as main transcriptc.1058C>T p.Thr353Ile missense_variant 3/31 NM_000261.2 P1
MYOCOSENST00000637303.1 linkuse as main transcriptc.235-2248G>A intron_variant 5 A2
MYOCENST00000638471.1 linkuse as main transcriptc.*396C>T 3_prime_UTR_variant, NMD_transcript_variant 4/45

Frequencies

GnomAD3 genomes
AF:
0.000414
AC:
63
AN:
152098
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00964
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000957
GnomAD3 exomes
AF:
0.000704
AC:
177
AN:
251394
Hom.:
0
AF XY:
0.000662
AC XY:
90
AN XY:
135862
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00919
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000182
AC:
266
AN:
1461808
Hom.:
1
Cov.:
31
AF XY:
0.000173
AC XY:
126
AN XY:
727216
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00474
Gnomad4 SAS exome
AF:
0.000267
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000629
Gnomad4 OTH exome
AF:
0.000762
GnomAD4 genome
AF:
0.000401
AC:
61
AN:
152216
Hom.:
1
Cov.:
32
AF XY:
0.000470
AC XY:
35
AN XY:
74416
show subpopulations
Gnomad4 AFR
AF:
0.000120
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00927
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000947
Alfa
AF:
0.000227
Hom.:
0
Bravo
AF:
0.000355
ExAC
AF:
0.000585
AC:
71
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingMendelicsAug 22, 2023- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeApr 22, 2021- -
Glaucoma of childhood Benign:1
Likely benign, reviewed by expert panelcurationClinGen Glaucoma Variant Curation Expert PanelFeb 20, 2022The c.1058C>T variant in MYOC is a missense variant predicted to cause substitution of Threonine by Isoleucine at amino acid 353 (p.Thr353Ile). The highest minor allele frequency of this variant was in the East Asian population of gnomAD (v2.1.1) = 0.009122, which met the >= 0.001 threshold set for BS1 (182 alleles out of 19,952, meeting the threshold of >= 5 of at least 2,000 observed alleles). The REVEL score = 0.316, which was neither above nor below the thresholds for PP3 (>= 0.7) or BP4 (<= 0.15), predicting a damaging or benign impact on MYOC function. A previous study (PMID: 16466712) demonstrated that the Thr353Ile protein had similar secretion levels to wild type myocilin protein and met the OddsPath threshold for BS3_Moderate (< 0.23), indicating that this variant did not impact protein function. As BS1 was met, PP1 did not apply and segregations were not counted. Although probands with juvenile or primary open angle glaucoma have been reported carrying this variant, PM2_Supporting was not met, therefore PS4 did not apply. In summary, this variant met the criteria to receive a score of -6 and to be classified as likely benign (likely benign classification range -2 to -6) for juvenile open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): BS1, BS3_Moderate. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.36
Cadd
Benign
16
Dann
Uncertain
0.99
DEOGEN2
Uncertain
0.68
D
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.56
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.67
T
MetaRNN
Benign
0.020
T
MetaSVM
Benign
-0.34
T
MutationAssessor
Benign
1.6
L
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-1.9
N
REVEL
Uncertain
0.32
Sift
Benign
0.070
T
Sift4G
Benign
0.15
T
Polyphen
0.73
P
Vest4
0.11
MVP
0.91
MPC
0.26
ClinPred
0.050
T
GERP RS
3.8
Varity_R
0.18
gMVP
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs137853277; hg19: chr1-171605522; API